Skip to main content
Caplight Logo









Ourobionics

Ourobionics

Private
WageningenHealthcare & Life Scienceshttps://www.ourobionics.com/

Last Round

Seed

Jan 30, 2024

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Ourobionics is a biotechnology company that develops advanced 4D biofabrication and cyborganic technologies to create complex human tissue models for drug discovery, regenerative medicine, and medical research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, 3D Printing, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

4D bioprintingbiofabricationtissue engineeringorgan-on-a-chipin-vitro testinghuman tissue modelscyborganicdrug discoveryanimal testing alternativesbiosensorsbioelectronicspreclinical testingregenerative medicinelab-grown tissuebiomaterials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ourobionics Comparables

Compare Ourobionics with similar companies based on industry and business-model similarity.

Ourobionics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vital3D Technologies
84%
Brinter
84%
BIO INX
81%

Ourobionics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 30, 2024
AcceleratorOct 29, 2021

Key People

Founding team and executive leadership

Stephen Gerard Gray

Founder & Executive Director (COO CSO)

Founding Team

John Zandbergen

CEO & Co-Founder

Founding Team

Ali Leylavi Shoushtari

Chief Technology Officer

Executive Team

Ourobionics Investors

Notable investors and investment history

Ourobionics investors
InvestorRounds
NXTGEN HightechSeed
Hello TomorrowAccelerator
East Netherlands Development Agency (Oost NL)Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 67% MoM, reaching 1.2K.

  • Jul 25, 2026

    Monthly visitors increased 353% MoM.

Ourobionics Filings

Explore SEC and related filing metadata, where available.

Ourobionics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ourobionics's valuation, stock price, and market status.

Is Ourobionics a public or private company?

Ourobionics is a private company.

What is the current stock price of Ourobionics?

Ourobionics is a private company with no public stock price. No recent secondary market data is available.

How much is Ourobionics worth (valuation)?

Valuation information for Ourobionics is not publicly available.

Can I buy Ourobionics stock?

Ourobionics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ourobionics's last funding round?

Ourobionics's most recent funding round was Seed on January 30, 2024.

Who are the main investors in Ourobionics?

Key investors in Ourobionics include East Netherlands Development Agency (Oost NL).

Will Ourobionics IPO soon?

No public IPO plans have been announced for Ourobionics.

How can I track Ourobionics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ourobionics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWageningen
Employee Range8
Year Founded2021
Last FundingJan 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?